[1] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132. [2] Gehlot P, Shukla V, Gupta S, et al.Detection of ALDH1 activity in rabbit hepatic VX2 tumors and isolation of ALDH1 positive cancer stem cells[J]. J Transl Med, 2016, 14:49. [3] Rous P, Beard JW.The progression to carcinoma of virus-induced rabbit papillomas (Shope)[J]. J Exp Med, 1935, 62: 523-548. [4] Kidd JG, Rous P.A transplantable rabbit carcinoma originating in a virus-induced papilloma and containing the virus in masked or altered form[J]. J Exp Med, 1940, 71:813-838. [5] 刘险峰, 任乐荣, 苏广彦, 等. 兔VX2肿瘤细胞系的建立及其生物学特性的观察[J]. 中华病理学杂志 , 2005, 34(10): 661-663. [6] 苏畅, 张惠中, 李文海, 等. 兔VX2肿瘤的离体培养及有关生物学特性[J]. 第四军医大学学报, 2006(9):844-847. [7] 赵中辛, 杜竞辉, 王学浩, 等. 毗喃霉素-碘油肝动脉灌注治疗兔VX2瘤的药代动力学研究[J]. 中华实验外科杂志, 1998, 15(3):244-245. [8] 王光大, 吴勇超, 李亚洲, 等. 兔VX2肝脏转移瘤血供来源分析[J]. 医学动物防制, 2017, 33(3):240-242+248+356. [9] Li JL, Ye WT, Liu ZY, et al.Comparison of microvascular perfusion evaluation among IVIM-DWI, CT perfusion imaging and histological microvessel density in rabbit liver VX2 tumors[J]. Magn Reson Imaging, 2018, 46:64-69. [10] Ahn SY, Goo JM, Lee KH, et al.Monitoring tumor response to the vascular disrupting agent CKD-516 in a rabbit VX2 intramuscular tumor model using PET/MRI: Simultaneous evaluation of vascular and metabolic parameters[J]. PLoS One, 2018, 13(2):1-14. [11] 丁玖乐, 陈蕾, 孙玲玲, 等. VX2瘤在不同CT机型下常规腹部扫描的纹理分析差异及预处理评价[J]. 中国医学影像学杂志, 2018, 26(1):7-10. [12] 余梁, 含笑, 周丽芬, 等. 兔VX2肝癌模型改良制作及TAE前后CT与DSA影像学评估[J]. 中国CT和MRI杂志, 2017, 15(8):85-87. [13] 于涛, 魏然, 金宇, 等. 兔VX2骨转移瘤的适宜穿刺活检时间研究[J]. 中华实用诊断与治疗杂志, 2017, 31(6):530-532. [14] Tong H, Duan LG, Zhou HY, et al.Modification of the method to establish a hepatic VX2 carcinoma model in rabbits[J]. Oncol Lett, 2018, 15(4):5333-5338. [15] 张贵祥, 孙诚, 魏梦绮, 等. 介绍兔VX2转移瘤动物模型[J]. 实用放射学杂志, 1998, 14(2):59. [16] Pascale F, Bédouet L, Fazel A, et al.Lymphatic transport and lymph node location of microspheres subcutaneously injected in the vicinity of tumors in a rabbit model of breast cancer[J]. Pharm Res, 2018, 35(10):191. [17] Zhang H, Xiong F, Qian K, et al.Transcatheter arterial embolization combined with hypoxia-replicative oncolytic adenovirus perfusion enhances the therapeutic effect of hepatic carcinoma[J]. Cancer Manag Res, 2019, 11:981-996. [18] 孙轶群, 童彤, 毛健, 等. VX2移植性兔直肠癌淋巴结转移动物模型的建立及其生物学特性[J]. 中国癌症杂志, 2016, 26(10):840-847. [19] 许健东, 方利平. 蜂胶对兔骨骼肌VX2肿瘤生长抑制作用的研究[J]. 临床合理用药杂志, 2016, 9(33):134-136. [20] 马雅昌, 郭健, 朱雅文, 等. 一项新型封闭穿刺技术应用于骨肿瘤穿刺活检中的价值[J]. 遵义医学院学报, 2018, 41(01):53-57+62. [21] 含笑, 胡茂能, 吴鸿峰, 等. 建立改良法兔VX2肝癌模型及肝动脉联合门静脉插管的应用[J]. 中国介入影像与治疗学, 2017, 14(11):690-693. [22] 金光鑫, 王军, 仇晓霞, 等. MR导引经皮穿刺瘤块种植法构建兔VX2肝癌模型[J]. 介入放射学杂志, 2016, 25(11): 980-983. [23] 张强, 李彬, 李晓光, 等. CT导引下“体外预装示踪一步植入技术”制作兔肝/肾肿瘤模型[J]. 介入放射学杂志, 2018, 27(03):252-256. [24] Li H, Yu L, Wang W, et al.Dynamics of angiogenesis and cellularity in rabbit VX2 tumors using contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging[J]. Oncol Lett, 2018, 15(3):2978-2984. [25] 潘江洋, 时高峰, 王琦, 等. DCE-MRI评估索拉非尼抑制兔VX2肝种植瘤血管生成的实验研究[J]. 放射学实践, 2018, 33(1):13-19. [26] 王攀鸽, 谭红娜, 王博, 等. MR淋巴造影显影兔VX2乳腺癌模型内乳前哨淋巴结[J]. 中国医学影像技术, 2018, 34(5):641-645. [27] Chen X, Liu HP, Li M, et al.Advances in non-surgical management of primary liver cancer[J]. World J Gastroenterol, 2014, 20(44):16630-16638. [28] 刘亚, 吕维富, 朱先海, 等. 兔肝VX2肿瘤射频消融后不同区带VEGF的表达和细胞凋亡[J]. 中国介入影像与治疗学, 2017, 14(9):561-565. [29] 邹孟达, 熊青, 邓青松, 等. 环五肽RGD靶向的纳米金偶联VEGFsiRNA增强兔VX2肝肿瘤射频消融损伤效应的研究[J]. 中国普通外科杂志, 2017, 26(1):43-49. [30] 赵艳萍, 齐玲俊, 刘文亚, 等. CT评价兔VX2肝癌射频消融后局部肿瘤进展模式及部位[J]. 中国医学影像技术, 2011, 27(3):474-478. [31] 明韦迪, 李晓光, 金征宇. 兔小腿VX2 肿瘤射频消融前后血清HSP70、IL-6、IL-8水平的变化及意义[J]. 医学影像学杂志, 2017, 27(5):906-910. [32] Bimonte S, Leongito M, Piccirillo M, et al.Radio-frequency ablation-based studies on VX2 rabbit models for HCC treatment[J]. Infect Agent Cancer, 2016, 11:38. [33] Jiang T, Zhang X, Ding J, et al.Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammation drug after incomplete radiofrequency ablation[J]. Int J Clin Exp Pathol, 2015, 8(11):13945-13956. [34] 李浩, 段旭华, 韩新巍, 等. 经肝动脉化疗栓塞术联合射频消融治疗兔肝VX2 肿瘤的效果分析[J]. 临床肝胆病杂志, 2018, 34(4):779-783. [35] Tomozawa Y, Nitta N, Ohta S, et al.Anti-tumor effects of sorafenib administered at different time points in combination with transarterial embolization in a rabbit VX2 liver tumor model[J]. Cardiovasc Intervent Radiol, 2017, 40(11): 1763-1768. [36] Zhang X, Dai F, Chen J, et al.Antitumor effect of curcumin liposome after transcatheter arterial embolization in VX2 rabbits[J]. Cancer Biol Ther, 2019, 8:1-11. [37] 黄巧胜, 陈少锋, 钟泽龙, 等. 雷替曲塞经不同给药方式的药动学分析[J]. 介入放射学杂志, 2018, 27(2):157-162. [38] 刘宇, 张福军, 兰作平, 等. 基于兔VX2原位移植肺癌模型评价多西他赛脂质体疗效和安全性[J]. 第三军医大学学报, 2017, 39(14):1428-1434. [39] 董胜利, 李高鹏, 宋建, 等. 纳米颗粒介导的P53联合Rb基因靶向治疗对兔VX2肝转移癌多药耐药的影响及分子机制[J]. 中国药物与临床, 2017, 17(4):468-471+618. [40] 梁琪, 邓灵灵, 冯智超, 等. SPIO纳米药物载体联合碘化油经肝动脉栓塞治疗兔VX2肝癌[J]. 中南大学学报: 医学版, 2017, 42(11):1248-1256. [41] 戴海涛, 黄勇慧, 林润, 等. 磷酰胆碱修饰的氧化石墨烯经导管动脉化疗栓塞治疗肝癌[J]. 中山大学学报: 医学版, 2018, 39(1):18-25. [42] Sun Y, Xiong X, Pandya D, et al.Enhancing tissue permeability with MRI guided preclinical focused ultrasound system in rabbit muscle: From normal tissue to VX2 tumor[J]. J Control Release, 2017, 256:1-8. [43] 陈云卫, 宋晓雪, 吴堃, 等. 腹腔镜下射频凝血器对家兔VX2肝癌模型的疗效研究[J]. 现代医药卫生, 2017, 33(23): 3546-3548. [44] 宋春慧, 赵伟, 李嫚, 等. 氩氦刀治疗兔VX2肝肿瘤的影像表现与病理分析[J]. 医疗装备, 2017, 30(9):1-3. [45] Oshiro H.The role of the lymphatic system in rabbit models for cancer metastasis research: a perspective from comparative anatomy[J]. Okajimas Folia Anat Jpn, 2014, 91(2): 25-28. [46] National Health and Family Planning Commission of the People's Republic of China. Diagnosis, management, and treatment of hepatocellular carcinoma (V2017)[J]. J Clin Hepatol, 2017, 33(8):1419-1431. [47] Urano M, Tanaka C, Sugiyama Y, et al.Antitumor effects of residual tumor after cryoablation: the combined effect of residual tumor and a protein-bound polysaccharide on multiple liver metastases in a murine model[J]. Cryobiology, 2003, 46:238-245. [48] Chandra D, Jahangir A, Cornelis F, et al.Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer[J]. Oncoimmunology, 2015, 5:e1049802. [49] 米金霞, 卢涛, 方肇勤, 等. 实体瘤中心变性粉碎引流术在兔VX2移植瘤模型实施的可行性评价[J]. 上海中医药大学学报, 2018, 32(5):41-44. [50] Huisman F, van Lienden KP, Damude S, et al. A review of animal models for portal vein embolization[J]. J Surg Res, 2014, 191(1):179-188. |